Advertisement
Review Article| Volume 36, ISSUE 4, P795-801, December 2016

Download started.

Ok

Clinical Toxicology and Its Relevance to Asthma and Atopy

Published:October 14, 2016DOI:https://doi.org/10.1016/j.cll.2016.07.005

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Available at: www.cdc.gov/asthma/asthmadata.htm. Accessed April 5, 2016.

        • Paulozzi L.J.
        • Jones C.M.
        • Mack K.A.
        • Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control
        • Center for Disease Control and Prevention
        • et al.
        Vital signs: overdoses of prescription opioid pain relievers – United States, 1999-2008.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 5
        • Center for Disease Control and Prevention
        Prescription painkiller overdoses: a growing epidemic, especially among women.
        Centers for Disease Control and Prevention, Atlanta (GA)2013 (Available at:)
        • Rudd R.A.
        • Aleshire N.
        • Zibbell J.E.
        Increases in drug and opioid overdose deaths–United States, 2000-2014.
        MMWR Morb Mortal Wkly Rep. 2016; 64: 1378-1382
        • Center for Disease Control and Prevention
        • National Center for Health Statistics
        • National Vital Statistics System, Mortality File
        Number and age-adjusted rates of drug-poisoning deaths involving opioid analgesics and heroin: United States, 2000-2014.
        Center for Disease Control and Prevention, Atlanta (GA)2015 (Available at:)
        • Choi H.
        • Krantz A.
        • Smith J.
        • et al.
        Medical diagnoses associated with substance dependence among inpatients at a large urban hospital.
        PLoS One. 2015; 10: e0131324
        • Krantz A.J.
        • Hershow R.C.
        • Pruchand N.
        • et al.
        Heroin insufflation as a trigger for patients with life-threatening asthma.
        Chest. 2003; 123: 510-517
        • Levenson T.
        • Greenberger P.A.
        • Donoghue E.R.
        • et al.
        Asthma deaths confounded by substance abuse. An Assessment of fatal asthma.
        Chest. 1996; 110: 604-610
        • Hlavaty L.
        • Hansma P.
        • Sung L.
        Contribution of opiates in sudden asthma deaths.
        Am J Forensic Med Pathol. 2015; 36: 49-52
        • Boto de los Bueis A.
        • Pereira Vega A.
        • Sánchez Ramos J.L.
        • et al.
        Bronchial hyperreactivity in patients who inhale heroin mixed with cocaine vaporized on aluminum foil.
        Chest. 2002; 121: 1223-1230
        • Centers for Disease Control and Prevention
        Increase in fentanyl drug confiscations and fentanyl-related overdose fatalities. HAN Health Advisory.
        US Department of Health and Human Services, CDC, Atlanta (GA)2015 (Available at:)
        • Parmar M.S.
        Exacerbation of asthma secondary to fentanyl transdermal patch.
        BMJ Case Rep. 2009; 2009 ([pii:bcr10.2008.1062])
        • Otani S.
        • Tokioka H.
        • Fujii H.
        • et al.
        A case of severe bronchospasm under epidural anesthesia with fentanyl.
        Masui. 1997; 46: 1378-1381
        • Tweed W.A.
        • Dakin D.
        Explosive coughing after fentanyl injection.
        Anesth Analg. 2001; 92: 1442-1443
        • Sabin J.A.
        • Greenwalt A.G.
        The influence of implicit bias on treatment recommendations for 4 common pediatric conditions: pain, urinary tract infection, attention deficit hyperactivity disorder, and asthma.
        Am J Public Health. 2012; 102: 988-995
        • Vijayaraghavan M.
        • Penko J.
        • Guzman D.
        • et al.
        Primary care providers’ judgments of opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults.
        J Gen Intern Med. 2011; 26: 412-418
      2. Available at: http://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf. Accessed April 5, 2016.

        • Weil J.V.
        • McCullough R.E.
        • Kline J.S.
        • et al.
        Diminished ventilator response to hypoxia and hypercapnia after morphine in normal man.
        N Engl J Med. 1975; 292: 1103-1106
      3. World Health Organisation (WHO). Community management of opioid overdose. Available at: http://www.who.int/substance_abuse/publications/management_opioid_overdose/en/.2014.

        • Chakravarty N.K.
        • Matallana A.
        • Jensen R.
        • et al.
        Central effects of antitussive drugs on cough and respiration.
        J Pharmacol Exp Ther. 1956; 117: 127-135
        • Foral P.A.
        • Maleskaer M.A.
        • Huerta G.
        • et al.
        Nebulized opioids use in COPD.
        Chest. 2004; 125: 691-694
        • Baydur A.
        Nebulized morphine: a convenient and safe alternative to dyspnea relief.
        Chest. 2004; 125: 363-365
        • Groneberg D.A.
        • Fischer A.
        Endogenous opioids as mediators of asthma.
        Pulm Pharmacol Ther. 2001; 14: 383-389
        • Liu S.Y.
        • Woo S.O.
        • Holmes M.J.
        • et al.
        LC and LC-MS-MS analyses of undeclared codeine in antiasthmatic Chinese proprietary medicine.
        J Pharm Biomed Anal. 2000; 22: 481-486
        • Eschenbacher W.L.
        • Bethel R.A.
        • Boushey H.A.
        • et al.
        Morphine sulfate inhibits bronchoconstriction in subjects with mild asthma whose response are inhibited by atropine.
        Am Rev Respir Dis. 1984; 130: 363-367
        • Field P.I.
        • Simmul R.
        • Bell S.C.
        • et al.
        Evidence for opioid modulation and generation of prostaglandins in sulphur dioxide (SO)2-induced bronchoconstriction.
        Thorax. 1996; 151: 159-163
        • Otulana B.
        • Okikawa J.
        • Linn L.
        • et al.
        Safety and pharmacokinetic of inhaled morphine delivered using the AERx system in patients with moderate-to-severe asthma.
        Int J Clin Pharmacol Ther. 2004; 42: 456-462
        • Pontopiddan H.
        • Geffen B.
        • Lowenstein E.
        Morphine for severe asthma?.
        N Engl J Med. 1973; 288: 50
        • Djukanovic R.
        • Hanania N.
        • Busse W.
        • et al.
        IgE-mediated asthma: new revelations and future insights.
        Respir Med. 2016; 112: 128-129
        • Prieto-Lastra L.
        • Iglesias-Cadarso A.
        • Reaño-Martos M.M.
        • et al.
        Pharmacological stimuli in asthma/urticarial.
        Allergol Immunopathol (Madr). 2006; 34: 224-227
        • Blunk J.A.
        • Schmelz M.
        • Zeck S.
        • et al.
        Opioid-induced mast cell activation and vascular responses is not mediated by μ-opioid receptors: an in vivo microdialysis study in human skin.
        Anesth Analg. 2004; 98: 364-370
        • Doenicke A.
        • Mass J.
        • Lorenz W.
        • et al.
        Intravenous morphine and nalbuphine increase histamine and catecholamine release without accompanying hemodynamic changes.
        Clin Pharmacol Ther. 1995; 58: 81-89
        • Ennis M.
        • Schneider C.
        • Nehring E.
        • et al.
        Histamine release induced by opioid analgesic: a comparative study using porcine mast cells.
        Agents Actions. 1991; 33: 20-22
        • Cygan J.
        • Trunsky M.
        • Corbridge T.
        Inhaled heroin-induced status asthmaticus. Five Cases and a review of the literature.
        Chest. 2000; 117: 272-275
        • Popa V.
        Codeine-induced bronchoconstriction and putative bronchial opiate receptors in asthmatic subjects.
        Pulm Pharmacol. 1994; 7: 333-341
        • Van Dorp E.
        • Yassen A.
        • Dahan A.
        Naloxone treatment in opioid addiction: the risks and benefits.
        Expert Opin Drug Saf. 2007; 6: 125-132
        • Merlin M.A.
        • Ariyaprakai N.
        • Arshad F.H.
        Assessment of the safety and ease of use of the naloxone auto-injector for the reversal of opioid overdose.
        Open Access Emerg Med. 2015; 2015: 21-24
        • Allegretti P.J.
        • Bzdusek J.S.
        • Leonard J.
        Caution with naloxone use in asthmatic patients.
        Am J Emerg Med. 2006; 24: 515-516
        • Tataris K.L.
        • Weber J.M.
        • Stein-Spencer L.
        • et al.
        The effect of prehospital nebulized naloxone on suspected heroin-induced bronchospasm.
        Am J Emerg Med. 2013; 31: 717-718
        • Pinkofsky H.B.
        • Hahn A.M.
        • Campbell F.A.
        • et al.
        Reduction of opioid-withdrawal symptoms with quetiapine.
        J Clin Psychiatry. 2005 Oct; 66: 1285-1288
        • Gotshall R.W.
        Exercise-induced bronchoconstriction.
        Drugs. 2002; 62: 1725-1739
        • Taiwo O.
        • Kovac K.
        • Sperry L.
        • et al.
        Naloxone induced morphine withdrawal increases the number and degranulation of mast cells in the thalamus of the mouse.
        Neuropharmacology. 2004; 46: 824-835
        • Panerai A.E.
        • Sacerdote P.
        Beta-endorphin in the immune system: a role at last?.
        Immunol Today. 1997; 18: 317-319
        • Zhu J.
        • Paul W.E.
        Peripheral CD4 T cell differentiation regulated by networks of cytokines and transcription factors.
        Immunol Rev. 2010; 238: 247-262
        • Roy S.
        • Wang J.
        • Charboneau R.
        • et al.
        Morphine induces CD4+ T cell IL-4 expression through an adenylyl cyclase mechanism independent of the protein kinase A pathway.
        J Immunol. 2005; 175: 6361-6367
        • Saroyan J.M.
        • Evans E.A.
        • Segoshi A.
        • et al.
        Interviewing and urine drug toxicology screening in a pediatric pain management center: an analysis of analgesic nonadherence and aberrant behaviors in adolescents and young adults.
        Clin J Pain. 2016; 32: 1-6